Table 2 Prognostic analysis of 12 candidate LNM-related genes in ovarian cancer
From: Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1
Gene | OS | PFS | ||
|---|---|---|---|---|
HRa ( 95%CIb) | P | HRa ( 95%CIb) | P | |
TUBA4B | 0.84 (0.74, 0.96) | 0.010 | 0.88 (0.78, 1.01) | 0.062 |
SPP1 | 1.31 (1.16, 1.50) |  < 0.001 | 1.38 (1.21, 1.57) |  < 0.001 |
RGS1 | 0.93 (0.82, 1.06) | 0.010 | 1.25 (1.09, 1.42) |  < 0.001 |
VTCN1 | 1.12 (0.97, 1.30) | 0.130 | 1.15 (0.99, 1.33) | 0.066 |
TMPRSS4 | 0.83 (0.73, 0.95) | 0.006 | 0.83 (0.73, 0.95) | 0.008 |
EPHX4 | 0.85 (0.69, 1.05) | 0.130 | 1.31 (1.05, 1.65) | 0.019 |
RUNX3 | 0.83 (0.72, 0.97) | 0.019 | 0.94 (0.82, 1.09) | 0.430 |
MUC16 | 0.83 (0.73, 0.95) | 0.005 | 1.21 (1.05, 1.41) | 0.010 |
SPON1 | 0.83 (0.73, 0.94) | 0.005 | 0.91 (0.79, 1.05) | 0.210 |
PCDHB2 | 1.31 (1.07, 1.62) | 0.010 | 1.49 (1.21, 1.84) |  < 0.001 |
MEOX1 | 1.16 (1.02, 1.32) | 0.021 | 1.21 (1.06, 1.38) | 0.005 |
SLC4A11 | 0.79 (0.64, 0.97) | 0.024 | 1.36 (1.11, 1.68) | 0.003 |